Advertisement

Pharmacologic and Nonpharmacologic Treatment for Acute Cough Associated With the Common Cold

CHEST Expert Panel Report
Published:August 22, 2017DOI:https://doi.org/10.1016/j.chest.2017.08.009

      Background

      Acute cough associated with the common cold (CACC) causes significant impairment in quality of life. Effective treatment approaches are needed for CACC. We conducted a systematic review on the management of CACC to update the recommendations and suggestions of the CHEST 2006 guideline on this topic.

      Methods

      This systematic review of randomized controlled trials (RCTs) asked the question: Is there evidence of clinically relevant treatment effects for pharmacologic or nonpharmacologic therapies in reducing the duration/severity of acute CACC? Studies of adults and pediatric patients with CACC were included and assessed for relevance and quality. Based on the systematic review, guideline suggestions were developed and voted on using the American College of Chest Physicians organization methodology.

      Results

      Six systematic reviews and four primary studies identified from updated literature searches for each of the reviews or from hand searching were included and reported data on 6,496 participants with CACC who received one or more of a variety of interventions. The studies used an assortment of descriptors and assessments to identify CACC.

      Conclusions

      The evidence supporting the management of CACC is overall of low quality. This document provides treatment suggestions based on the best currently available evidence and identifies gaps in our knowledge and areas for future research.

      Key Words

      Abbreviations:

      CACC (cough associated with the common cold), CHEST (American College of Chest Physicians), FDA (Food and Drug Administration), NSAID (nonsteroidal anti-inflammatory drug), OTC (over the counter), RCT (randomized controlled trial), VAS (visual analogue scale)
      To read this article in full you will need to make a payment
      Subscribe to CHEST
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Druce H.M.
        • Dicpinigaitis P.
        • Eccles R.
        • Turner R.
        • Adeleke M.
        Nationwide internet survey on the symptom of cough associated with common cold.
        J Gen Intern Med. 2016; 31: S309-S310
      1. Centers for Disease Control and Prevention. Common colds: protect yourself and others. http://www.cdc.gov/features/rhinoviruses/. Accessed April 30, 2016.

        • Dicpinigaitis P.V.
        • Eccles R.
        • Blaiss M.S.
        • Wingertzahn M.A.
        Impact of cough and common cold on productivity, absenteeism, and daily life in the United States: ACHOO survey.
        Curr Med Res Opin. 2015; 31: 1519-1525
      2. Consumer Healthcare Products Association. Statistics on OTC use. http://www.chpa.org/marketstats.aspx. Accessed May 14, 2016.

      3. Consumer HealthCare Products Association. Statistics on OTC use. OTC Sales by Category 2013-2016. Available at: http://www.chpa.org/OTCsCategory.aspx. Accessed June 08, 2016.

        • Johnsen M.
        Cough-Cold Report 2016.
        Drug Store News. February 2016; (Accessed June 8, 2016)
        • Pratter M.R.
        Cough and the common cold: ACCP evidence-based clinical practice guidelines.
        Chest. 2006; 129: 72S-74S
        • Lewis S.Z.
        • Diekemper R.
        • Ornelas J.
        • Casey K.R.
        Methodologies for the development of CHEST guidelines and expert panel reports.
        Chest. 2014; 146: 182-192
        • Lewis S.Z.
        • Diekemper R.L.
        • French C.T.
        • Gold P.M.
        • Irwin R.S.
        • Chest Expert Cough Panel
        Methodologies for the development of the management of cough: CHEST guideline and expert panel report.
        Chest. 2014; 146: 1395-1402
        • Huang X.
        • Lin J.
        • Demner-Fushman D.
        Evaluations of PICO as a knowledge representation for clinical questions.
        AMIA Annu Symp Proc. 2006; : 359-363
        • Higgins J.P.
        • Altman D.G.
        • Gotzsche P.C.
        • et al.
        The Cochrane Collaboration’s tool for assessing risk of bias in randomized trials.
        BMJ. 2011; 343: d5928
        • Diekemper R.
        • Ireland B.
        • Merz L.
        Development of the documentation and appraisal review tool (DART) for systematic reviews.
        BMJ Qual Saf. 2013; 22: 61-62
        • Song M.
        • Happ M.
        • Sandelowski M.
        Development of a tool to assess fidelity to a psycho-educational intervention.
        J Adv Nurs. 2010; 66: 673-682
        • Chalumeau M.
        • Duijvestijn Y.C.M.
        Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease.
        Cochrane Database Syst Rev. 2013; : CD003124
        • De Sutter A.I.M.
        • Saraswat A.
        • van Driel M.L.
        Antihistamines for the common cold.
        Cochrane Database Syst Rev. 2015; : CD009345
        • Dicpinigaitis P.V.
        • Dhar S.
        • Johnson A.
        • Gayle Y.
        • Brew J.
        • Caparros-Wanderley W.
        Inhibition of cough reflex sensitivity by diphenhydramine during acute viral respiratory tract infection.
        Int J Clin Pharm. 2015; 37: 471-474
        • Kim S.Y.
        • Chang Y.J.
        • Cho H.M.
        • Hwang Y.W.
        • Moon Y.S.
        Non-steroidal anti-inflammatory drugs for the common cold.
        Cochrane Database Syst Rev. 2015; 9: CD006362
        • Paul I.M.
        • Beiler J.
        • McMonagle A.
        • Shaffer M.L.
        • Duda L.
        • Berlin C.M.
        Effect of honey, dextromethorphan, and no treatment on nocturnal cough and sleep quality for coughing children and their parents.
        Arch Pediatr Adolesc Med. 2007; 161: 1140-1146
        • Shadkam M.N.
        • Mozaffari-Khosravi H.
        • Mozayan M.R.
        A comparison of the effect of honey, dextromethorphan, and diphenhydramine on nightly cough and sleep quality in children and their parents.
        J Altern Complement Med. 2010; 16: 787-793
        • Oduwole O.
        • Meremikwu M.M.
        • Oyo-Ita A.
        • Udoh E.E.
        Honey for acute cough in children.
        Cochrane Database Syst Rev. 2014; 12 (CD007094.0.1002/14651858)
        • Singh M.
        • Das R.R.
        Zinc for the common cold.
        Cochrane Database Syst Rev. 2013; 6: CD001364
        • Hemilä H.
        • Chalker E.
        The effectiveness of high dose zinc acetate lozenges on various common cold symptoms: a meta-analysis.
        BMC Family Pract. 2015; 16: 24
        • Petrus E.J.
        • Lawson K.A.
        • Bucci L.R.
        • Blum K.
        Randomized, double-masked, placebo-controlled clinical study of the effectiveness of zinc acetate lozenges on common cold symptoms in allergy tested subjects.
        Curr Ther Res. 1998; 59: 595-607
        • Prasad A.S.
        • Fitzgerald J.T.
        • Bao B.
        • Beck FWJ Chandrasekar P.H.
        Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate: a randomized double-blind, placebo-controlled trial.
        Ann Intern Med. 2000; 133: 245-252
        • Prasad A.S.
        • Beck F.W.J.
        • Bao B.
        • Smel D.
        • Fitzgerald J.T.
        Duration and severity of symptoms and levels of plasma interleukin-1 receptor antagonist, soluble tumor necrosis factor receptor, and adhesion molecules in patients with common cold treated with zinc acetate.
        J Infect Dis. 2008; 197: 795-802
        • Rerksuppaphol S.
        • Rerksuppaphol L.
        A randomized controlled trial of chelated zinc for prevention of the common cold in Thai school children.
        Paediatr Int Child Health. 2013; 33: 145-150
        • Smith S.M.
        • Schroeder K.
        • Fahey T.
        Over-the-counter (OTC) medications for acute cough in children and adults in community settings.
        Cochrane Database Syst Rev. 2014; 11: CD001831
        • Paul I.M.
        • Beiler J.S.
        • King T.S.
        • Clapp E.R.
        • Vallati J.
        • Berlin C.M.
        Vapor Rub, petrolatum, and no treatment for children with nocturnal cough and cold symptoms.
        Pediatrics. 2010; 126: 1092-1099
        • Paul I.M.
        • Beiler J.S.
        • Vallati J.R.
        • Duda L.M.
        • King T.S.
        Placebo effect in the treatment of acute cough in infants and toddlers: a randomized clinical trial.
        JAMA Pediatr. 2014; 168: 1107-1113
      4. US National Library of Medicine. Daily Med. Vituz (hydrocodone bitartrate and chlorpheniramine) package insert. Morristown, NJ: Hawthorn Pharmaceuticals, Inc. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=35ecdec3-4a59-479f-a3cb-4ffe0d4ab85e. Accessed May 12, 2016.

      5. US National Library of Medicine. Daily Med. Obredon (hydrocodone bitartrate and chlorpheniramine) package insert. East Windsor, NJ: Accelis Pharma, Inc. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=31c14c1c-a250-4891-b6ab-9c5961fc8a39. Accessed May 12, 2016.

      6. US National Library of Medicine. Daily Med. Flowtuss (hydrocodone bitartrate and guaifenesin) package insert. San Antonio, TX: Mission Pharmacal. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1d0c2c03-ca11-30b1-e054-00144ff8d46c. Accessed May 12, 2016.

      7. US National Library of Medicine. Daily Med. Tuzistra XR (codeine polistirex and chlorpheniramine polistirex) package insert. Berwyn, PA; Vernalis Therapeutics, Inc. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aebefc5e-5487-42ef-98f7-01d26eb38362. Accessed May 12, 2016.

      8. US National Library of Medicine. Daily Med. Hycofenix (hydrocodone bitartrate, pseudoephedrine, and guaifenesin) package insert. San Antonio, TX: Mission Pharmacal. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1cfa7c8f-0309-3591-e054-00144ff8d46c. Accessed May 12, 2016.

      9. US Food and Drug Administration. Most young children with a cough or cold don't need medicines. FDA consumer update. January 17, 2008. http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm048682.htm. Accessed May 12, 2016.

        • Ostroff C.
        • Lee C.E.
        • McMeekin J.
        Unapproved prescription cough, cold, and allergy products. Recent US Food and Drug Administration regulatory action on unapproved cough, cold, and allergy medications.
        Chest. 2011; 140: 295-300
      10. US Food and Drug Administration. Codeine cough-and-cold medicines in children: drug safety communication - FDA evaluating potential risk of serious side effects, July 7, 2015. http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm453379.htm. Accessed May 12, 2016.

      11. Opioid pain or cough medicines combined with benzodiazepine: drug safety communication—FDA requiring boxed warning about serious risks and death, August 31, 2016. http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm518710.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery. Accessed August 31, 2016.

        • Linn K.A.
        • Long M.T.
        • Pagel P.S.
        “Robo-tripping”: dextromethorphan abuse and its anesthetic implications.
        Anesth Pain Med. 2014; 4: e20990
        • Burns J.M.
        • Boyer E.W.
        Antitussives and substance abuse.
        Subst Abuse Rehabil. 2013; 4: 75-82
        • Albrecht H.H.
        Can big data analysis help speed up the clinical development of mucoactive drugs for symptomatic RTIs?.
        Lung. 2016; 194: 31-34
        • Eccles R.
        • Turner R.B.
        • Dicpinigaitis P.V.
        Treatment of acute cough due to the common cold: multi-component, multi-symptom therapy is preferable to single-component, single-symptom therapy—a pro/con debate.
        Lung. 2016; 194: 15-20